Bayer Logo Bayer USA

Claritin has made a three-year commitment of up to a half a million dollars to help kids get outside and moving.

Americans spend a startling 95% of their time indoors – even though spending as little as 20 minutes outside in nature can make you feel happy, according to a recent survey. To encourage people to get outside, Claritin partnered with actress and outdoor enthusiast Hilary Duff and Boys & Girls Clubs of America to launch the 20 Minutes of Spring Project in April 2018.

The 20 Minutes of Spring Project marks year two of the three-year commitment and continues the simple message from year one: GET OUTSIDE. Studies suggest spending time outdoors in nature has been associated with health benefits such as feelings of reduced stress, improved mood and increased energy.

In year one, Claritin and Boys & Girls Clubs of America developed an outdoor activity resource, the Play Breaks Guide, to help support staff at 4,300 Clubs in getting their local youth outside and keeping them active. This year, Hilary Duff, Claritin and kids from the Boys & Girls Club of America Harlem Club (PS 125 site) kick off their very own 20 Minutes of Spring Project with a new Imagination Playground, a portable playground that allows children to explore and build the play space they want.

To learn more about the Claritin 20 Minutes of Spring Project, simple ways to get involved and more about how you can help Boys & Girls Clubs of America, visit Claritin.com/20MinutesofSpring.

About Bayer: Science For A Better Life

Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2017, the Group employed around 99,800 people and had sales of EUR 35.0 billion. Capital expenditures amounted to EUR 2.4 billion, R&D expenses to EUR 4.5 billion. For more information, go to www.bayer.us.